Simplex Trading’s Epirus Biopharmaceuticals EPRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-509
Closed -$96K – 7043
2015
Q4
$96K Sell
509
-23
-4% -$104 0.01% 1398
2015
Q3
$90K Buy
+532
New +$3.12K 0.01% 1499
2015
Q1
– Sell
-11
Closed -$2K – 6394
2014
Q4
$2K Buy
+11
New +$57 ﹤0.01% 3987

Simplex Trading's EPRS Position: Q1 2016 in Review

Simplex Trading sold out of Epirus Biopharmaceuticals (EPRS) in Q1 2016, closing a stake of 43,008 shares — an estimated $132K sold.

Simplex Trading first reported a position in EPRS in Q4 2014 and held it in 3 quarters. The position peaked at $132K in Q4 2015. 37 funds tracked by Wall St. Rank hold EPRS as of Q1 2016.

  • Simplex Trading reported no remaining Epirus Biopharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Simplex Trading sold 43,008 Epirus Biopharmaceuticals shares in Q1 2016, an estimated $132K.
  • Simplex Trading first reported a position in Epirus Biopharmaceuticals in Q4 2014 and held it in 3 quarters.
  • Simplex Trading's Epirus Biopharmaceuticals position peaked at $132K in Q4 2015.
  • 37 funds tracked by Wall St. Rank held Epirus Biopharmaceuticals as of Q1 2016.

Based on Simplex Trading's 13F filing for Q1 2016, filed 14 Apr 2016.